The collaboration between world renowned doctors and scientists facilitates testing and implementing new treatments for diabetes and its complications, and evaluating the long-term effects and the cost-effectiveness of new therapeutic programs in modern day health care management.
The contributions of the research program at MGH to laboratory and clinical research in diabetes over the past thirty years, both autoimmune Type 1 diabetes and Type 2 diabetes, have been of exceptional importance.
Type 1 Diabetes - A Cure in Sight?
MGH diabetes investigators have made a number of recent discoveries which have raised the possibility that a cure for Type1 diabetes can be achieved in as little as 3-5 years. By cure, we mean the permanent restoration of normal blood sugar and the permanent elimination of the need for any ongoing therapy for blood sugar control.
Click here for to learn more about how MGH researchers cured diabetic (NOD) mice, for the first time ever.
Type 2 Diabetes - New Therapies & Preventatives
The large multicenter research study led by Dr. David Nathan, the Diabetes Prevention Program has recently announced some very positive results on the prevention of Type 2 diabetes. However, the problems of Type 2 diabetes are especially complex and a cure does not seem likely in the short term. Nevertheless, we anticipate that a sophisticated analysis of human genomics together with the application of modern molecular and cellular biology will enable the development of effective new therapies and preventatives.
Click here for to learn about the Diabetes Prevention Program
Click here for to learn about Research in Type 2 Diabetes.
|
|
